https://www.pharmaceutical-technology.com/data-insights/mitoxantrone-hydrochloride-cspc-pharmaceutical-group-hepatocellular-carcinoma-likelihood-of-approval/?utm_source=lgp5-loa&utm_medium=24-304747&utm_campaign=recommended-articles-pi
Mitoxantrone hydrochloride is under clinical development by CSPC Pharmaceutical Group and currently in Phase I for Hepatocellular Carcinoma.
cspc pharmaceutical groupmitoxantrone hydrochloridehepatocellular carcinomalikelihood